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Abstract 
Introduction: Acute respiratory infections (ARIs) are major causes of morbidity in early childhood. They are mainly caused by viruses, 
including influenza (INF) and respiratory syncytial viruses (RSV). We aimed to investigate the role of RSV and INF in children hospitalized 
for ARIs and to show the impact of RSV/INF rapid testing on management of patients.  
Methodology: Cross-sectional study using data of inpatient care of children younger than five years hospitalized in Arabkir Medical Center 
due to ARI from November 1, 2013 to April 1, 2014. Nasopharyngeal swabs were tested for RSV and INF types A and B by direct antigen 
detection tests.  
Results: A total of 915 patients, 583 (63.7%) boys and 332 (36.3%) girls were included in the study with the mean age of 18.8 ± 16.3 months. 
Among them, 390 (42.6%) were tested positive, 3 (0.3%) subjects tested positive both for RSV and INF: 269 (29.4%) for RSV and 124 (13.6%) 
for INF (A – 121, B – 3). Out of 915 children, 209 (23%) were pretreated with antibiotics, most often with oral amoxicillin/clavulanic acid (n 
= 54, 25.8%), sulfamethoxazole/trimethoprim (n = 46, 22%), and amoxicillin (n = 38, 18.2%), followed by intramuscular ceftriaxone (n = 37, 
17.7%). 
Conclusions: The usage of antigen tests for detection of respiratory viruses allowed to document high rates of RSV and INF in children admitted 
to the hospital. In settings where polymerase chain reaction method is not readily available, implementation of rapid tests for detection of 
respiratory viruses is important in the management of pediatric patients including cohorting and more targeted use of antibiotics. 
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Introduction 
Respiratory tract infections are the most common 
diseases of infants and young children often caused by 
respiratory syncytial virus (RSV) and influenza (INF) 
type A and type B. 
Respiratory syncytial virus is a leading cause of 
acute respiratory infections (ARIs) in patients of all 
ages. Infants are infected during the first year of life, 
with nearly all having been infected at least once by the 
second birthday. Most RSV-infected infants experience 
upper respiratory tract symptoms, and 20-30% develop 
lower respiratory tract disease with their first infection. 
Virtually all children have serologic evidence of RSV 
infection by 2 years of age. Nevertheless, previous RSV 
infections do not provide protection against reinfections 
[1].  
Children younger than 5 years of age, especially 
those younger than 2 years old, are at high risk of 
serious INF related complications, hospitalization, 
emergency department visits and death [2,3].  
The clinical manifestations of viral infections are 
often indistinguishable from ARIs of other etiologies. 
Overlap of symptoms between viral and bacterial 
infections may lead to inappropriate antibiotic 
prescriptions, leading to the development of resistant 
bacterial species, which is a nowadays of ever greater 
importance [4]. Hence, accurate and timely laboratory 
testing is needed to guide clinical management. 
Among the methods that have been developed to 
diagnose viral pathogens, cell cultures are complicated, 
expensive, and time consuming. Although, the 
polymerase chain reaction (PCR) method is widely 
used for detection of respiratory pathogens because of 
its high sensitivity and specificity, rapid antigen 
detection tests (RADTs) remain practical tools for the 
detection of respiratory viruses in clinical practice. 
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Antigen-based assays are inexpensive and easy to 
perform [5,6]. Additionally, due to its high cost, the 
PCR method is not readily available in developing 
countries with limited resources such as Armenia. 
Despite the public health concern about the role of 
RSV- and INF-induced infections among children, 
there have been no any publications available in Peer 
review journals so far concerning the situation in 
Armenia.  
The aim of this study was to investigate the impact 
of rapid RSV/INF detection on the management of 0-5 
year-old patients hospitalized with ARIs. 
In a tertiary level children’s hospital in Yerevan, 
Armenia, for the period of November 2013-April 2014, 
we determined: a) incidence and clinical course of RSV 
and INF in hospitalized children; b) prescription 
patterns of antibiotics and systemic steroids in RSV-
/INF-positive and -negative groups. 
 
Methodology 
Study Design 
Cross-sectional study based on the inpatient care 
data from the Arabkir Joint Medical Center (JMC), a 
tertiary level children’s hospital in Yerevan, Armenia. 
 
Study setting 
General: Armenia is an ex-Soviet developing 
country, located at the crossroads of Europe and Asia. 
About a fifth of its 3-million population is under 18 
years of age [7,8].  
Specific: Arabkir JMC is one of the three biggest 
tertiary level children’s hospitals of Armenia, where 
patients can apply directly or be referred from primary 
and/or secondary healthcare facilities. It serves around 
15.000 inpatients and up to 100.000 outpatients 
annually. 
Antibiotics have always been related to prescription 
drugs in Armenia, however, the requirements were not 
met in full force. Citizens of the country were getting 
antibiotics without prescriptions at the pharmacies. 
Since March 1, 2018 in Armenia, according to the 
updated regulations, pharmacies are obliged to release 
antibiotics only on prescription of a doctor. 
 
Study site, population and period 
The study was conducted from November 1, 2013 
to April 1, 2014 in Arabkir JMC and included 0-5-
years-old patients with symptoms of ARI. Study 
patients were prospectively tested for the RSV, INF-A 
and INF-B infections using OSOM® tests (Sekisui 
Diagnostics, San Diego, USA): 
immunochromatographic assay for the qualitative 
detection of viral antigens from nasal swab or nasal 
suction specimens. Nasopharyngeal swabs, sampled in 
universal virological transport tube, were taken when 
the patient was admitted with the symptoms of ARI. 
Only the patients who had an OSOM® RSV/INF A, B 
test and parental/care-giver consent were included in 
the study. Exclusion criteria were duration of fever for 
more than 7 days (low probability of viral infection), 
and antibiotic pre-treatment for more than 3 days (to 
allow evaluation of possible secondary bacterial 
complications and needs of antibiotic prescription). 
 
Data collection, sources and statistical analysis 
Data were extracted from patients’ medical records 
using data collection sheet, specifically developed for 
this purpose. Abstracted data was entered into 
Microsoft Access electronic database for analyses. 
Variables collected included the following 
sociodemographic and clinical characteristics: age, 
gender, oxygen saturation, presence or absence and 
duration of fever and respiratory symptoms, final 
diagnosis, chest radiography interpretations, common 
blood count results and C-reactive protein levels, 
prescribed antibiotics, hospitalization units (general 
pediatric ward, intensive care unit) and length of 
hospitalization. Data were analyzed using the STATA 
software (Version 12). After conducting descriptive 
analyses (means, medians, standard deviations, and 
frequencies), the χ2 test or non-parametric Fisher’s 
exact test, as appropriate, was used to test differences in 
proportions of independent variables between RSV-
/INF-positive and RSV-/INF-negative groups. The 
mean differences in different groups were tested using 
Student’s t-test. The level of significance was set at 5%. 
 
Ethics Approval 
The study was approved by the Institutional Review 
Board of the Yerevan State Medical University, 
Armenia. 
 
Results 
A total of 915 patients, including 583 (63.7%) boys 
and 332 (36.3%) girls were included in the study. Their 
mean age was 18.8 ± 16.3 months. Positive test was 
recorded in 390 (42.6%) patients, with 3 (0.3%) 
subjects tested positive both for RSV and INF: 269 
(29.4%) for RSV and 124 (13.6%) for INF (INF A – 
121 and INF B – 3), respectively. Half of admitted 
children (n = 460, 50.3%) were self-referred evading 
their primary care facilities.  
Among 915 children, 209 (23%) received 
pretreatment with antibiotics: the most commonly were 
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oral amoxicillin/clavulanic acid (n = 54, 25.8%), 
sulfamethoxazole/trimethoprim (n = 46, 22%), and 
amoxicillin (n = 38, 18.2%), followed by intramuscular 
ceftriaxone (n = 37, 17.7%). 
Demographic data and clinical presentation of 
children with RSV and INF infection are summarized 
in Table 1 and Table 2, respectively.  
The RSV infection manifested as 
bronchiolitis/acute obstructive bronchitis (AOB) and 
was associated with significantly increased rates of 
admission to intensive care unit (ICU) (13.38% versus 
7.24%, p = 0.005) as well as increased rates of 
administration of steroids (51.7% versus 29.5%, p < 
0.01). Cases of INF infection were more likely to 
present as uncomplicated ARI (82.26%) with 
hospitalization to general pediatric wards.  
Although the rates of antibiotic prescriptions were 
unchanged during hospitalization, the trends of 
administred drugs were different. The most commonly 
used antibiotics in the RSV-positive group were 
ampicillin (25/79, 31.6%) and amoxicillin (21/79, 
26.6%), while ceftriaxone (9/31, 29%) was at the top of 
prescriptions in the INF-positive group.  
No case of invasive bacterial infection was 
documented during the study period. 
 
Discussion 
The present study documented the high rates of 
RSV (29.4%) and INF (13.55%) among hospitalized 
children under five years old with ARI in our hospital. 
Half of all included children avoided to visit their 
primary care institutions and were self-referred to the 
tertiary level hospital. This illustrates the importance of 
developing efficient mechanisms to enhance the 
“gatekeepers” function by reinforcing the network of 
primary care institutions.  
We showed that RSV infection clinically 
manifested as AOB/bronchiolitis with predominantly 
respiratory symptoms on admission, increased 
Table 1. Comparative demographic and clinical characteristics of RSV-positive and RSV-/INF-negative patients. 
Variable 
Total 
N = 794 
RSV-positive 
N = 269 
RSV-/INF- 
negative 
N = 525 
Odds Ratio / 
Mean difference 
95% CI 
p 
value 
Age, n (%) 
0-1 year 393 (49.5%) 83 (30.86%) 310 (59.05%) 3.23 2.37 – 4.41 < 0.012 
1-5 years1 401 (50.5%) 186 (69.14%) 215 (40.95%) 1 -  
Gender, n (%) 
Female 287 (36.15%) 101 (37.55%) 186 (35.43%) 0.91 0.67 – 1.24 0.562 
Male1 507 (63.85%) 168 (62.45%) 339 (64.57%) 1 - - 
Comorbidities, n (%) 
No 606 (76.32%) 209 (77.7%) 397 (75.62%) 0.89 0.63 – 1.26 0.522 
Yes1 188 (23.68%) 60 (22.3%) 128 (24.38%) 1 - - 
Pretreatment with antibiotics, n (%) 
No1 603 (75.94%) 191 (71%) 412 (78.48%) 1 - - 
Yes 185 (23.3%) 76 (28.25%) 109 (20.76%) 0.66 0.47 – 0.93 0.022 
Do not remember 6 (0.76%) 2 (0.74%) 4 (0.76%) 0.93 0.13 – 10.34 13 
Hospitalization ward, n (%) 
ICU 74 (9.32%) 36 (13.38%) 38 (7.24%) 0.51 0.31 – 0.82 < 0.012 
Pediatric1 720 (90.68%) 233 (86.62%) 487 (92.76%) 1 - - 
Antibiotic during hospitalization, n (%) 
No 570 (71.79%) 190 (70.63%) 380 (72.38%) 1.09 0.79 – 1.51 0.602 
Yes1 224 (28.21%) 79 (29.37%) 145 (27.62%) 1 - - 
Systemic steroids during hospitalization, n (%) 
No 500 (62.97%) 130 (48.33%) 370 (70.48%) 2.55 1.88 – 3.46 < 0.012 
Yes1 294 (37.03%) 139 (51.67%) 155 (29.52%) 1 - - 
Clinical diagnosis, n (%) 
ARI1 247 (31.11%) 4 (1.49%) 243 (46.29%) 1 - - 
Laryngotracheitis 57 (7.18%) 3 (1.12%) 54 (10.29%) 0.3 0.05 – 2.09 0.133 
Pneumonia with effusion 14 (1.76%) 1 (0.37%) 13 (2.48%) 0.22 0.02 – 11.34 0.243 
Pneumonia 74 (9.32%) 30 (11.15%) 44 (8.38%) 0.02 0.01 – 0.07 < 0.013 
AOB / Bronchiolitis 402 (50.63%) 231 (85.87%) 171 (32.57%) 0.01 0 – 0.03 < 0.013 
Hospital stay in days, mean (SD) 8.66 (5.65) 8.82 (5.65) 8.58 (5.66) -0.24 (0.42) -1.13 – 0.64 0.594 
1 Reference Group; 2 Pearson's Chi-Square test; 3 Fisher's exact test; 4 Student's t-test; AOB – acute obstructive bronchitis. ARI – acute respiratory infection. CI 
– confidence interval. ICU – intensive care unit. INF – influenza virus. RSV – respiratory syncytial virus. SD – standard deviation. 
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consumption of systemic steroids, longer hospital days 
and frequent hospitalization in ICU department.  
Most INF cases were diagnosed as uncomplicated 
ARI. In the INF-positive group, ceftriaxone was the 
most commonly prescribed antibiotic and fever was 
reported as the main indication for its administration. 
No patient received any antiviral treatment such as 
zanamivir or oseltamivir. 
The rate of RSV infection was similar to findings in 
Turkey (32%) – the western neighbor of Armenia, in 
contrast to studies in the southern bordering country 
Iran (19.4%) [9]. The incidence of INF infection in 
different countries is varying (10-40%) because of 
dissimilar preventive immunization programs [10,11]. 
The rate of antibiotic prescriptions during 
hospitalization was not different in RSV- and INF-
positive and negative patients. However, the most 
commonly used antibiotics in the RSV-group were 
ampicillin and amoxicillin. This might be explained by 
the fact that the indications for administration of 
antibiotics in RSV-positive patients were more targeted 
to otitis or pneumonia while children with INF (and 
high fever) rather were treated with ceftriaxone. This 
shift from WHO Watch group of antibiotics to Access 
group is one important step toward antimicrobial 
stewardship strategies [12].  
We documented no case of invasive bacterial 
infection during the study. Possible explanation for this 
may be early administration of antibiotics in outpatient 
and hospital levels.  
Previous studies from other countries found that 
rapid viral diagnosis leads to optimized clinical care, 
reduced antibiotic use, helps infection control and is 
cost effective [13-17].  
We strongly advocate for implementation of the 
rapid point-of-care tests for detection of respiratory 
virus antigens in hospitals in countries with limited 
resources. This helps to identify the burden of 
respiratory viruses and has the potential to enhance 
rational management of patients admitted with 
Table 2. Comparative demographic and clinical characteristics INF-positive and RSV-/INF-negative patients. 
Variable 
Total 
N = 649 
INF-positive 
N = 124 
RSV-/INF- 
negative 
N = 525 
Odds Ratio / 
Mean difference 
95% CI p value 
Age, n (%) 
0-1 year 397 (61.17%) 87 (70.16%) 310 (59.05%) 1.63 1.07 – 2.49 0.022 
1-5 years1 252 (38.83%) 37 (29.84%) 215 (40.95%) 1 - - 
Gender, n (%) 
Female 231 (35.59%) 45 (36.29%) 186 (35.43%) 1.04 0.69 – 1.56 0.862 
Male1 418 (64.41%) 79 (63.71%) 339 (64.57%) 1 - - 
Comorbidities, n (%) 
No 498 (76.73%) 101 (81.45%) 397 (75.62%) 1.42 0.86 – 2.32 0.172 
Yes1 151 (23.27%) 23 (18.55%) 128 (24.38%) 1 - - 
Pretreatment with antibiotics, n (%) 
No 512 (78.89%) 100 (80.65%) 412 (78.48%) 1 - - 
Yes1 133 (20.49%) 24 (19.35%) 109 (20.76%) 0.91 0.55 – 1.49 0.692 
Do not remember 4 (0.62%) 0 (0%) 4 (0.76%) 0 [0, 6.33] 13 
Hospitalization ward, n (%) 
ICU 45 (6.93%) 7 (5.65%) 38 (7.24%) 0.77 0.33 – 1.76 0.532 
Pediatric1 604 (93.07%) 117 (94.35%) 487 (92.76%) 1 - - 
Antibiotic during hospitalization, n (%) 
No 473 (72.88%) 93 (75%) 380 (72.38%) 1.14 0.73 – 1.79 0.562 
Yes1 176 (27.12%) 31 (25%) 145 (27.62%) 1 - - 
Systemic steroids during hospitalization, n (%) 
No 473 (72.88%) 103 (83.06%) 370 (70.48%) 2.05 1.24– 3.41 < 0.012 
Yes 176 (27.12%) 21 (16.94%) 155 (29.52%) 1 - - 
Clinical diagnosis, n (%) 
ARI1 345 (53.16%) 102 (82.26%) 243 (46.29%) 1 - - 
Laryngotracheitis 61 (9.4%) 7 (5.65%) 54 (10.29%) 0.31 0.14 – 0.7 < 0.012 
Pneumonia with effusion 15 (2.31%) 2 (1.61%) 13 (2.48%) 0.37 [0.04, 1.67] 0.253 
Pneumonia 53 (8.17%) 9 (7.26%) 44 (8.38%) 0.49 0.23 – 1.04 0.062 
AOB / Bronchiolitis 175 (26.96%) 4 (3.23%) 171 (32.57%) 0.06 0.01 – 0.15 < 0013 
Hospital stay in days, mean (SD) 8.51 (5.63) 8.16 (5.52) 8.58 (5.66) -0.42 (0.55) -1.65 – 0.8 0.504 
1 Reference Group; 2 Pearson's Chi-Square test; 3 Fisher's exact test; 4 Student's t-test; AOB – acute obstructive bronchitis. ARI – acute respiratory infection. CI 
– confidence interval. ICU – intensive care unit. INF – influenza virus. RSV – respiratory syncytial virus. SD – standard deviation. 
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respiratory infections. Timely identification of viruses 
can also be crucial for the cohorting of patients, 
especially during the winter season, when hospital beds 
are overloaded. 
The study was conducted during the first season of 
implementation of RADTs. We anticipate that during 
the next seasons the use of laboratory tests, chest X-rays 
and antibiotics will be drastically reduced and further 
studies are necessary to assess their impact.  
The study strengths include the selection of the 
largest tertiary level pediatric hospital as the study site 
and inclusion of all eligible hospitalized under-five 
patients with ARI across the study period. Data were 
sourced from patient files, double entered and validated 
and thus we believe robust, and we adhered to STROBE 
guidelines for the reporting of observational studies 
[18]. One of the main limitations of the study is that our 
data is restricted to one of the three tertiary level 
children’s hospitals in the country. Another limitation 
is that the RADT results were not rechecked by PCR 
method. Notwithstanding these limitations, the study 
has a number of policy and practice implications. First 
of all it shows high rate of hospitalization due to RSV- 
and INF-infection. A high rate of influenza infection 
requires special attention and could be decreased by 
immunization of high-risk patients. 
Second, the study raises the problem of patients 
evading their primary care facilities: half of the patients 
were self-referred. There must be a national effort to 
rethink how to practice primary care. Finally, the 
excessive use of antibiotics and overuse of third 
generation cephalosporins are issue in primary care 
facilities as well as in tertiary level hospital. That could 
be partially explained by the absence of national 
guidelines for the management of respiratory infections 
among children. This issue could be improved by 
implementation of guidelines and antibiotic 
stewardship programs by Ministry of Health. 
 
Conclusion 
In conclusion, the antigen tests for detection of 
respiratory viruses allowed documenting high rates of 
RSV and INF in children admitted to Arabkir JMC. In 
settings where PCR method is not readily available, 
implementation of rapid antigen tests for recognition of 
respiratory viruses is important. It will improve the 
management of patient cohorting, targeted use of 
antibiotics, and efficient use of other diagnostic 
methods and facilities. 
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